Endra Life Sciences Stock News

Citius Pharmaceuticals, Inc. (CTXR) with the stream of -2.05% also noticed, India ENDRA Life Sciences Inc. (NDRA) encountered a rapid change of -9.11% in the last hour of Monday’s trading … The post Up to Date Stock in Review: Citius Pharmaceuticals, Inc. (NASDAQ:CTXR), ENDRA Life Sciences Inc. (NASDAQ:NDRA) appeared first on Stocks Equity .

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Kezar Life Sciences Reports Positive Interim Phase 2 Data For Lupus Nephritis Treatment Candidate Keza

ENDRA Life Sciences Inc. (NDRA) delivered earnings and revenue surprises of 14.29% and -100.00%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for th

ENDRA Life Sciences' (NDRA) CEO Francois Michelon on Q3 2021 Results - Earnings Call Transcript

ANN ARBOR, Mich.--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today reported financial results for the three months ended September 30, 2021 and provided a business update. Highlights of the third quarter of 2021 and recent weeks include: Patient screening was initiated at the University of Pittsburgh Medical Center (UPMC) while it continues to work through a pandemic-related backlog of MRI procedures. Both the UPM

ENDRA Life Sciences Inc. (NDRA) delivered earnings and revenue surprises of 14.29% and -100.00%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for th

Stifel Financial Corp purchased a new stake in ENDRA Life Sciences Inc. (NASDAQ:NDRA) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 12,500 shares of the companys stock, valued at approximately $27,000. Several other hedge funds also recently bought []

ENDRA Life Sciences (NASDAQ:NDRA) is scheduled to release its earnings data after the market closes on Monday, November 15th. Analysts expect ENDRA Life Sciences to post earnings of ($0.07) per share for the quarter. Persons interested in participating in the companys earnings conference call can do so using this link. ENDRA Life Sciences (NASDAQ:NDRA) last []

ANN ARBOR, MI / ACCESSWIRE / September 7, 2021 / ENDRA Life Sciences Inc. (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that management will participate in two u

ENDRA Life Sciences' (NDRA) CEO Francois Michelon on Q2 2021 Results - Earnings Call Transcript

ANN ARBOR, MI / ACCESSWIRE / July 20, 2021 / ENDRA Life Sciences Inc. (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that management will participate in A.G.P.'s

ANN ARBOR, MI / ACCESSWIRE / June 15, 2021 / ENDRA Life Sciences Inc. (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announced the appointment of Irina Pestrikova as Senior

ENDRA Life Sciences Inc. (NDRA) CEO Francois Michelon on Q1 2021 Results - Earnings Call Transcript

Conference call begins at 4:30 p.m. Eastern time today ANN ARBOR, MI / ACCESSWIRE / May 17, 2021 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (T